[
  {
    "ts": null,
    "headline": "2 Beaten-Down Stocks to Buy on the Dip",
    "summary": "Among them are CRISPR Therapeutics (NASDAQ: CRSP) and Merck (NYSE: MRK), two companies that develop innovative medical therapies.  CRISPR Therapeutics' shares are down by 41% over the trailing-12-month period, while Merck's have declined by 22%.  It's not hard to figure out why CRISPR Therapeutics, a gene-editing specialist, isn't performing well.",
    "url": "https://finnhub.io/api/news?id=3a49b5cda79451bb0ee3ddf0fd71e0bafa7b8f0d2ef400c5c5a912bfd53fa6d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742673840,
      "headline": "2 Beaten-Down Stocks to Buy on the Dip",
      "id": 133325401,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Among them are CRISPR Therapeutics (NASDAQ: CRSP) and Merck (NYSE: MRK), two companies that develop innovative medical therapies.  CRISPR Therapeutics' shares are down by 41% over the trailing-12-month period, while Merck's have declined by 22%.  It's not hard to figure out why CRISPR Therapeutics, a gene-editing specialist, isn't performing well.",
      "url": "https://finnhub.io/api/news?id=3a49b5cda79451bb0ee3ddf0fd71e0bafa7b8f0d2ef400c5c5a912bfd53fa6d7"
    }
  },
  {
    "ts": null,
    "headline": "BUZZ Investing: Fed's Glimmer Of Hope Amid Market Corrections",
    "summary": "BUZZ Investing: Fed's Glimmer Of Hope Amid Market Corrections",
    "url": "https://finnhub.io/api/news?id=03408afa1952080181545aeb839354c59d0d91de887cdbdfbdbaa304f5c44835",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742613600,
      "headline": "BUZZ Investing: Fed's Glimmer Of Hope Amid Market Corrections",
      "id": 133312894,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=03408afa1952080181545aeb839354c59d0d91de887cdbdfbdbaa304f5c44835"
    }
  }
]